Restricted accessResearch articleFirst published online 1982-7
A Study to Ascertain Whether Hydrocortisone 17-butyrate (Locoid®) 0·1% Cream Has Any Effect on the Hypothalamic-Pituitary-Adrenal Axis in Children with Skin Diseases
A study was conducted in eight children requiring topical corticosteroid treatment for dermatological disorders. The trial was carried out with hydrocortisone 17-butyrate (Locoid®) 0·1% cream. The children were treated twice daily with Locoid cream applied to areas involving at least 20% of the body surface for a period of 2 to 3 weeks. Statistical analysis did not reveal any significant changes in plasma cortisol levels after treatment compared to pre-treatment baseline levels. No side-effects were reported.
Get full access to this article
View all access options for this article.
References
1.
FeiwelMJamesV H TBarnettE S (1969) Effect of potent topical steroids on plasma cortisol levels of infants and children with eczema. Lancet1, 485.
2.
GillK ABaxterD L (1964) Plasma cortisol suppression by steroid creams. Archives of Dermatology (Chicago)89, 734.
3.
HerzG (1972) Modernes Kortikoid-Kombinationexternum für die pädiatrische Dermotherapie. Ärztliche Praxis24, 483.
4.
HerzG (1973) Kortikoidexterna in der pädiatrischen Praxis. Hans Marseille Verlag, Munich.
5.
ScogginsR BKlimanB (1965) Percutaneous absorption of corticosteroids: Systemic effects. New England Journal of Medicine273, 831.
